Примери за използване на Review programme на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
substance/ product-type combinations in part 2 of Annex II to the Review Programme Regulation, substances where previous participants made a timely withdrawal,
Where the evaluation of an active substance demonstrates that it does not exactly match the identity of the substance as originally included in the Review Programme(Part 1 of Annex II of the biocides Review Regulation), the substance identity
Furthermore, the Review Programme Regulation provides a defined role for ECHA
additional precursor(s)/active substance/product type(PT) combinations that are introduced as a result of the redefinition of the in situ generated active substances currently in the review programme the deadline of 1 September 2015 will not apply, and the obligations under Article 95 will only apply at a later date i.e.
whose notification was rejected in accordance with Article 11 will be permitted to participate in the review programme only collectively with one
together with the name of the notifying company(“participant” in accordance with Article 2(c) of the Review Programme Regulation).
The Review Programme.
The Review Programme.
The Review Programme.
Existing active substances(Review programme).
Substance/product-type combinations eligible for inclusion in the review programme.
In exceptional cases, active substance/product-type combinations can be added to the review programme.
In Annex II part 1 of the Review Programme Regulation, the active substances which are under evaluation are listed.
Manufacturers and importers not involved with the review programme of the previous legislation have to submit certain information to ECHA.
check that the active substance in the product is in the Review Programme.
Review programme is the work programme originally established by the European Commission for assessment of existing active substances used in biocidal products.
are evaluated under the Review Programme are referred to as existing active substances.
If the active substance is not yet approved but is in the Review Programme, the biocidal product can be made available
to amend the Annexes and to adopt the review programme.
If companies wish to take over the role of a participant under the review programme for these combinations they need to make a notification,